CardioKinetix has developed a novel transcatheter implant called the Parachute Ventricular Partitioning Device (Parachute). The Parachute is designed to be a catheter-based partitioning device deployed within the left ventricle for patients who have developed ischemic left sided heart failure following a heart attack. The Parachute implant partitions the damaged muscle, isolating the non-functional muscle segment from the functional segment, which decreases the overall volume and restores a more normal geometry and function in the left ventricle.
CardioKinetix total Funding
CardioKinetix latest funding size
Time since last funding
|4 years ago|
|Cutlass Capital, Lexington Partners, Edwards Lifesciences, Panorama Capital, SV Health Investors, New Leaf Venture Partners|